| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-07 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |